Kaya Holdings (KAYS) Total Current Liabilities (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Total Current Liabilities of $2.5 million in Q3 2025, down 79.04% quarter-over-quarter from $12.1 million in Q2 2025, and down 72.12% on a YoY basis from $9.1 million in Q3 2024.
Kaya Holdings (KAYS) Total Current Liabilities (2011 - 2025) Analysis & Trends
Kaya Holdings' Total Current Liabilities history runs 15 years deep, the most recent figure standing at $2.5 million for Q3 2025.
- In Q3 2025, Total Current Liabilities fell 72.12% year-over-year to $2.5 million; the TTM figure through Sep 2025 stood at $2.5 million (down 72.12% YoY), while the FY2024 annual figure was $8.1 million, up 9.43% from the prior year.
- Total Current Liabilities was $2.5 million for Q3 2025 at Kaya Holdings, down from $12.1 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $25.7 million in Q1 2021 to a low of $2.5 million in Q3 2025.
- Historically, Total Current Liabilities has averaged $10.1 million across 5 years, with a median of $9.1 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities surged 83.95% in 2023, then slumped 72.12% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $8.1 million in 2021, then advanced by 28.78% to $10.4 million in 2022, then dropped by 28.92% to $7.4 million in 2023, then gained by 9.43% to $8.1 million in 2024, then slumped by 68.73% to $2.5 million in 2025.
- The last three Total Current Liabilities figures came in at $2.5 million (Q3 2025), $12.1 million (Q2 2025), and $9.7 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | 2.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 12.09 Mn |
| Mar 31, 2025 | 9.66 Mn |
| Dec 31, 2024 | 8.10 Mn |
| Sep 30, 2024 | 9.09 Mn |
| Jun 30, 2024 | 7.79 Mn |
| Mar 31, 2024 | 8.29 Mn |
| Dec 31, 2023 | 7.40 Mn |
| Sep 30, 2023 | 7.77 Mn |
| Jun 30, 2023 | 10.01 Mn |
| Mar 31, 2023 | 9.69 Mn |
| Dec 31, 2022 | 10.42 Mn |
| Sep 30, 2022 | 12.88 Mn |
| Jun 30, 2022 | 5.44 Mn |
| Mar 31, 2022 | 8.77 Mn |
| Dec 31, 2021 | 8.09 Mn |
| Sep 30, 2021 | 12.05 Mn |
| Jun 30, 2021 | 16.12 Mn |
| Mar 31, 2021 | 25.70 Mn |
| Dec 31, 2020 | 20.30 Mn |